Literature DB >> 9762628

Reducing waiting times in lung cancer.

P C Deegan1, L Heath, J Brunskill, W J Kinnear, S A Morgan, I D Johnston.   

Abstract

BACKGROUND: Concern exists over delays in the management of lung cancer patients. Maximum waiting times and a multidisciplinary team (MDT) approach have been recommended in several recent national reports.
OBJECTIVE: Having implemented a MDT approach, we wished to assess whether national recommendations were achievable and to identify the major factors causing delays.
METHODS: Prospective survey over five months of all new referrals with suspected lung cancer, documenting waiting times at all stages from referral to definitive treatment.
RESULTS: Of the total of 92 patients, 57 were outpatients (67% seen within one week, 89% within two weeks of receipt of referral) and 35 were inpatients (all seen within two working days). Patient age did not influence waiting times to first being seen or to investigation. The result of the initial diagnostic test was received within two weeks of first being seen in 86% of patients. All patients received definitive treatment within recommended times from diagnosis. Delays in the early part of the care pathway were largely due to potentially remediable service factors, but unavoidable patient related factors were important in some prolonged diagnostic delays.
CONCLUSIONS: National recommendations on waiting times are achievable in a high proportion of cases. The probable importance of the MDT approach is discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9762628

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  10 in total

1.  Effect of delays on survival in patients with lung cancer.

Authors:  Francisco Javier González-Barcala; José María García-Prim; José Manuel Alvarez-Dobaño; Milagros Moldes-Rodríguez; María Teresa García-Sanz; Antonio Pose-Reino; Luis Valdés-Cuadrado
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.

Authors:  G Kasymjanova; D Small; V Cohen; R T Jagoe; G Batist; W Sateren; P Ernst; C Pepe; L Sakr; J Agulnik
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

3.  How do general practitioners respond to reports of abnormal chest X-rays?

Authors:  W S Lim; J T Macfarlane; P C Deegan; A Manhire; W F Holmes; D R Baldwin
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

Review 4.  Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:  Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

5.  Delays to surgery in non-small-cell lung cancer.

Authors:  Moishe Liberman; Dan Liberman; John S Sampalis; David S Mulder
Journal:  Can J Surg       Date:  2006-02       Impact factor: 2.089

6.  Implementation of the British Thoracic Society recommendations for organising the care of patients with lung cancer: the surgeon's perspective.

Authors:  J Lee; A Marchbank; P Goldstraw
Journal:  Ann R Coll Surg Engl       Date:  2002-09       Impact factor: 1.891

7.  Effect of delays on prognosis in patients with non-small cell lung cancer.

Authors:  G Myrdal; M Lambe; G Hillerdal; K Lamberg; Th Agustsson; E Ståhle
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

8.  Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study.

Authors:  Hugh Ip; Tarik Amer; Michael Dangoor; Affan Zamir; Darryl Gibbings-Isaac; Ranjeev Kochhar; Timothy Heymann
Journal:  JRSM Short Rep       Date:  2012-10-15

9.  Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?

Authors:  R H Jack; M C Gulliford; J Ferguson; H Møller
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

10.  Predicting delays in lung cancer diagnosis and staging.

Authors:  Virginia Leiro-Fernández; Cecilia Mouronte-Roibás; Esmeralda García-Rodríguez; Maribel Botana-Rial; Cristina Ramos-Hernández; María Torres-Durán; Alberto Ruano-Raviña; Alberto Fernández-Villar
Journal:  Thorac Cancer       Date:  2019-01-03       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.